TR200704897A1 - Uzatılmış salım sağlayan gliklazid formülasyonları@ - Google Patents

Uzatılmış salım sağlayan gliklazid formülasyonları@

Info

Publication number
TR200704897A1
TR200704897A1 TR2007/04897A TR200704897A TR200704897A1 TR 200704897 A1 TR200704897 A1 TR 200704897A1 TR 2007/04897 A TR2007/04897 A TR 2007/04897A TR 200704897 A TR200704897 A TR 200704897A TR 200704897 A1 TR200704897 A1 TR 200704897A1
Authority
TR
Turkey
Prior art keywords
extended release
glyclazide
providing extended
formulations providing
relates
Prior art date
Application number
TR2007/04897A
Other languages
English (en)
Inventor
��Fter �M�T
�Ner Levent
T�Rkyilmaz Al�
Original Assignee
Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket�
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� filed Critical Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket�
Priority to TR2007/04897A priority Critical patent/TR200704897A1/tr
Priority to EP09157027A priority patent/EP2087884A2/en
Priority to EP08104732A priority patent/EP2090299A3/en
Priority to US12/171,932 priority patent/US20090017116A1/en
Publication of TR200704897A1 publication Critical patent/TR200704897A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, uzatılmış salım sağlayan farmasötik dozaj şekli olarak bir tablet bileşiminin oral uygulaması ve üretim yöntemleriyle ilgilidir. Mevcut buluş daha özel olarak insan hastalarda kan glikoz düzeyini yükseltmeyen uzatılmış salım sağlayan gliklazid formülasyonuyla ilgilidir.
TR2007/04897A 2007-07-13 2007-07-13 Uzatılmış salım sağlayan gliklazid formülasyonları@ TR200704897A1 (tr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2007/04897A TR200704897A1 (tr) 2007-07-13 2007-07-13 Uzatılmış salım sağlayan gliklazid formülasyonları@
EP09157027A EP2087884A2 (en) 2007-07-13 2008-07-11 Extended Release Gliclazide Formulations
EP08104732A EP2090299A3 (en) 2007-07-13 2008-07-11 Extended Release Gliclazide Formulations
US12/171,932 US20090017116A1 (en) 2007-07-13 2008-07-11 Extended release gliclazide formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2007/04897A TR200704897A1 (tr) 2007-07-13 2007-07-13 Uzatılmış salım sağlayan gliklazid formülasyonları@

Publications (1)

Publication Number Publication Date
TR200704897A1 true TR200704897A1 (tr) 2009-02-23

Family

ID=38947358

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2007/04897A TR200704897A1 (tr) 2007-07-13 2007-07-13 Uzatılmış salım sağlayan gliklazid formülasyonları@

Country Status (3)

Country Link
US (1) US20090017116A1 (tr)
EP (2) EP2087884A2 (tr)
TR (1) TR200704897A1 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI20130184A1 (it) * 2013-08-01 2015-02-02 Valpharma Internat S P A Una formulazione farmaceutica di gliclazide a rilascio modificato, somministrabile per via orale, e suo metodo di produzione.
CN113876727B (zh) * 2021-11-02 2023-04-18 江西制药有限责任公司 一种格列齐特缓释片及其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018373A1 (fr) * 1999-02-01 2000-04-06 Adir Et Compagnie Comprime matriciel permettant la liberation prolongee de gliclazide apres administration par voie orale
CN1437934A (zh) * 2003-01-03 2003-08-27 南昌弘益科技有限公司 一种能提高难溶性药物溶出速率和生物利用度的工艺技术
CN1711991A (zh) * 2004-06-14 2005-12-28 北京德众万全药物技术开发有限公司 一种难溶性药物的控释制剂
WO2006061697A1 (en) * 2004-12-06 2006-06-15 Themis Laboratories Private Limited Sulfonylurea compositions and a process for its preparation
WO2006123213A1 (en) * 2005-05-18 2006-11-23 Ranbaxy Laboratories Limited Modified release formulations of gliclazide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132376C (tr) 1966-02-10
DE3320582A1 (de) 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
AU785288B2 (en) * 2000-01-28 2006-12-21 Azopax Therapeutics Llc Slow release protein polymers
US20020132780A1 (en) * 2001-01-12 2002-09-19 Heisey Matthew Thomas Low carbohydrate compositions, kits thereof, and methods of use
US6703045B2 (en) 2001-08-21 2004-03-09 Council Of Scientific & Industrial Research Composition and method for maintaining blood glucose level
WO2005105109A1 (fr) 2004-04-29 2005-11-10 Lotus Pharmaceutical Co., Ltd. Pastilles a liberation orale modifiee et leur procede de preparation
IS8660A (is) * 2007-07-02 2009-01-03 Actavis Group Ptc Ehf. Gliklasíð lyfjasamsetning

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018373A1 (fr) * 1999-02-01 2000-04-06 Adir Et Compagnie Comprime matriciel permettant la liberation prolongee de gliclazide apres administration par voie orale
CN1437934A (zh) * 2003-01-03 2003-08-27 南昌弘益科技有限公司 一种能提高难溶性药物溶出速率和生物利用度的工艺技术
CN1711991A (zh) * 2004-06-14 2005-12-28 北京德众万全药物技术开发有限公司 一种难溶性药物的控释制剂
WO2006061697A1 (en) * 2004-12-06 2006-06-15 Themis Laboratories Private Limited Sulfonylurea compositions and a process for its preparation
WO2006123213A1 (en) * 2005-05-18 2006-11-23 Ranbaxy Laboratories Limited Modified release formulations of gliclazide

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE CA CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002465778, retrieved from STN Database accession no. 145: 443892 *
DATABASE CA CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002465779, retrieved from STN Database accession no. 142: 379435 *

Also Published As

Publication number Publication date
EP2090299A2 (en) 2009-08-19
US20090017116A1 (en) 2009-01-15
EP2087884A2 (en) 2009-08-12
EP2090299A3 (en) 2010-11-24

Similar Documents

Publication Publication Date Title
EA201290171A1 (ru) Вводимые перорально кортикостероидные композиции
PH12015500407A1 (en) Methods of treating hypertriglyceridemia
EA201690102A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
MY161593A (en) Oral formulations of cytidine analogs and methods of use thereof
MX2013014788A (es) Liberacion modificada de 4-metil-3-[[4-(3-piridinl)-2-pirimidinil] -amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-fenil ]-benzamida solubilizada utilizando acidos organicos.
TW200640497A (en) Pharmaceutical formulations and methods of use
EP2545939A3 (en) Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
MY145999A (en) Preventing diseases in infants delivered via caesarean section
GT200600445A (es) Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo.
WO2008027557A3 (en) Topiramate compositions and methods of enhancing its bioavailability
MX343358B (es) Tabletas de acetato de ulipristal.
TW200806289A (en) Sustained-release formulation of zonisamide
JP2007238598A5 (tr)
MX2009011316A (es) Derivados del acido lipoico.
BRPI0513598A (pt) formas de dosagem em comprimidos revestidos de liberação entérica
TR200900878A2 (tr) Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
MY156302A (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ß-AMYLOID DISEASES AND SYNUCLEINOPATHIES
EA201171497A1 (ru) Снижение флуктуаций опиоидов в крови
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
PH12015500823A1 (en) Modified release formulations for oprozomib
NZ592049A (en) Compositions and methods for the treatment of bowel diseases with granulated mesalamine
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
TR200900879A2 (tr) Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler
TR200806300A2 (tr) Çözünürlük artırıcı farmasötlk formulasyon